mutLBSgeneDB |
Gene summary for NBR1 |
Gene summary |
Basic gene Info. | Gene symbol | NBR1 |
Gene name | neighbor of BRCA1 gene 1 | |
Synonyms | 1A1-3B|IAI3B|M17S2 | |
Cytomap | UCSC genome browser: 17q21.31 | |
Type of gene | protein-coding | |
RefGenes | NM_001291571.1, NM_001291572.1,NM_005899.4,NM_031862.3,NM_031858.2, | |
Description | B-box proteincell migration-inducing gene 19 proteinmembrane component, chromosome 17, surface marker 2 (ovarian carcinoma antigen CA125)migration-inducing protein 19next to BRCA1 gene 1 protein | |
Modification date | 20141222 | |
dbXrefs | MIM : 166945 | |
HGNC : HGNC | ||
Ensembl : ENSG00000188554 | ||
HPRD : 01326 | ||
Vega : OTTHUMG00000180878 | ||
Protein | UniProt: Q14596 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_NBR1 | |
BioGPS: 4077 | ||
Pathway | NCI Pathway Interaction Database: NBR1 | |
KEGG: NBR1 | ||
REACTOME: NBR1 | ||
Pathway Commons: NBR1 | ||
Context | iHOP: NBR1 | |
ligand binding site mutation search in PubMed: NBR1 | ||
UCL Cancer Institute: NBR1 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0016236 | macroautophagy | 19250911 | GO:0051259 | protein oligomerization | 19250911 |
Top |
Ligand binding site mutations for NBR1 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | I44 | Q45E | BLCA | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for NBR1 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | I44 | Q45E | -0.93387541 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for NBR1 from PDB |
Top |
Differential gene expression and gene-gene network for NBR1 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for NBR1 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for NBR1 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of NBR1 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | CL | CHLORIDE | 2g4s | A | I44 |
Top |
Conservation information for LBS of NBR1 |
Multiple alignments for Q14596 in multiple species |
LBS | AA sequence | # species | Species | E24 | LVSDPENTTWA | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | E65 | SQGEYEEALKM | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | I44 | FDLNTIQIKYL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K36 | VEAMVKVSFDL | 2 | Mus musculus, Rattus norvegicus | K36 | IEAMVKVSFDL | 1 | Homo sapiens | L68 | EYEEALKMANI | 2 | Mus musculus, Rattus norvegicus | L68 | EYEEALKMA-V | 1 | Homo sapiens | P23 | FLVSDPENTTW | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | Q61 | ISINSQGEYEE | 2 | Mus musculus, Rattus norvegicus | Q61 | VSINSQGEYEE | 1 | Homo sapiens | T26 | SDPENTTWADV | 2 | Mus musculus, Rattus norvegicus | T26 | SDPENTTWADI | 1 | Homo sapiens | T43 | SFDLNTIQIKY | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | Y64 | NSQGEYEEALK | 3 | Homo sapiens, Mus musculus, Rattus norvegicus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |